ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Scientists will use use stem cells to grow ‘mini brains’ using Neanderthal DNA – Digital Trends

Continue reading

2018-05-16 Michael Zand NEWS

Scientists will use use stem cells to grow ‘mini brains’ using Neanderthal DNA – Digital Trends


Digital Trends

Scientists will use use stem cells to grow ‘mini brains’ using Neanderthal DNA
Digital Trends
Did we somehow wake up in a Michael Crichton novel without realizing it? First, Harvard University sets out to bring the woolly mammoth back to life. Now, researchers from Germany’s Max Planck Institute for Evolutionary Anthropology have stated their …

Continue reading

2018-05-16 Michael Zand NEWS

Deal Watch: Novo’s Increased Cell Therapy Commitment Includes Stem Cell Pact With BioLamina – In Vivo


Digital Trends

Scientists will use use stem cells to grow ‘mini brains’ using Neanderthal DNA
Digital Trends
Did we somehow wake up in a Michael Crichton novel without realizing it? First, Harvard University sets out to bring the woolly mammoth back to life. Now, researchers from Germany’s Max Planck Institute for Evolutionary Anthropology have stated their …

Continue reading

2018-05-16 Michael Zand NEWS

Japan keeps edge in stem-cell medicine with heart study – Nikkei Asian Review


In Vivo

Deal Watch: Novo’s Increased Cell Therapy Commitment Includes Stem Cell Pact With BioLamina
In Vivo
Also, TapImmune merger with Marker could yield T-cell therapies that address multiple tumor-associated antigens with a better safety profile than CAR-T therapy. Bluebird and Medigene expand their TCR therapy collaboration. Already Registered? Sign in …

Continue reading

2018-05-16 Michael Zand NEWS

Dr. Ghosh on Frontline Immunotherapy in Hodgkin Lymphoma – OncLive

OncLiveDr. Ghosh on Frontline Immunotherapy in Hodgkin LymphomaOncLiveGhosh says that there may be a role for immunotherapy in the frontline setting. There are trials of immunotherapy currently ongoing, but there is not yet a head-to-head comparison. … Continue reading

2018-05-16 Michael Zand NEWS

bluebird bio (BLUE) to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti … – StreetInsider.com

bluebird bio (BLUE) to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti …StreetInsider.combluebird bio, Inc. (Nasdaq: BLUE) announced that updated interim data from CRB-401, its Phase 1 study of bb2121, an anti-… Continue reading

2018-05-16 Michael Zand NEWS

bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR … – Business Wire (press release)

Business Wire (press release)bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR …Business Wire (press release)CAMBRIDGE, Mass.–(BUSINESS WIRE)–bluebird bio, Inc. (Nasdaq: BLUE) announced… Continue reading

2018-05-16 Michael Zand NEWS

Jennifer Doudna delivers Prather Lectures, explaining her gene-editing technology – Harvard Gazette


Nikkei Asian Review

Japan keeps edge in stem–cell medicine with heart study
Nikkei Asian Review
TOKYO/OSAKA — Japan’s decision on Wednesday to greenlight a study using stem cells for treating heart failure shows how far the field has progressed in the decade since the cells were first developed. The health ministry approved Osaka University’s …

and more »

Continue reading

2018-05-16 Michael Zand NEWS
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Jennifer Doudna delivers Prather Lectures, explaining her gene-editing technology
Harvard Gazette
Jennifer Doudna, the gene-editing pioneer whose breakthrough in CRISPR technology has taken the scientific world by storm, expressed surprise Tuesday evening at how fast the world’s scientists have put her findings to work, as well as concern that …